Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 14th Apr'24 to 24th Apr'24
Cosmetic Testing for US FDA Compliance
- Microbiological Testing for Cosmetics
- Animal Testing & Cosmetics
- Potential Contaminants
- Color Additives & Batch Certification
- Select Cosmetic Ingredients: Prohibited & Restricted Ingredients
- Shelf Life/Expiration Dating
- Nanomaterials in Cosmetics
- Cosmetic Good Manufacturing Practices (GMP) Compliance Testing
Overview of the webinar
The US Food and Drug Administration (FDA) holds cosmetic manufacturers and distributors responsible for the safety and quality of their cosmetics. This webinar serves to guide cosmetic manufacturers and distributors as well as other entities such as color additive manufacturers and analytical and microbiological laboratories on
FDA recommendations and requirements concerning the safety and quality testing of cosmetics. Topic areas covered in this webinar include FDA considerations for microbiological testing, animal testing, potential contaminants, nanomaterials in cosmetics, cosmetic good manufacturing practices (GMP) compliance testing, shelf life/expiration dating, select cosmetic ingredients and color additive batch certification.
Who should attend?
- CEOs & COOs
- Project Managers
- Executive Management
- Distributors
- Finished Product Cosmetic Ingredient Manufacturers
- Microbiological Laboratories
- Regulatory Executives
- Quality Executives
- Regulatory Management
- Quality & Compliance Management
- Operations Management
- GMP
- Top and Mid-Level Management
Why should you attend?
FDA periodically analyzes cosmetics, especially if aware of a potential problem. The information obtained can be used to alert consumers, support regulatory actions. To avoid action from the regulatory body. Cosmetic manufacturing companies should test the cosmetic product before it starts selling the product. Attend this webinar to learn different types of cosmetic testing which are practiced in the cosmetic industry to achieve compliance with the US FDA.
Faculty - Ms.Rachelle D’Souza
Rachelle D’Souza, CEO of Regulatory Heights Inc., has successfully licensed various medical and consumer products and facilities with international regulatory authorities/agencies for multinational and start-up companies. Her expertise also includes clinical trial master file documentation, and the design and maintenance of globally compliant quality, safety/pharmacovigilance and medical information systems.
At Regulatory Heights Inc, Rachelle continuously monitors the current regulatory environment and utilizes regulatory intelligence as a strategic business driver for her clientele. Her numerous articles on the latest international regulatory developments have been published in print and on-line by regulatory professional associations and industry magazines around the world.Her versatility has enabled Regulatory Heights Inc. to support companies, in particular, start-ups with the licensing of their drugs and medical devices in international markets.